https://pipelinereview.com/werewolf-therapeutics-presents-preclinical-results-demonstrating-anti-tumor-effects-of-pro-inflammatory-cytokine-therapeutics-wtx-518-and-wtx-712-at-aacr-2024-annual-meeting/